Abdullah, Wahida B.
HRN: 21-29-91 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2022
AMPICILLIN 1GM (VIAL)
05/05/2022
05/11/2022
IV
1g
Q6
PROM
Waiting Final Action
06/06/2023
CO-AMOXICLAV 625MG (TAB)
06/18/2023
06/25/2023
ORAL
625 Mg
BID
Septicemia
Waiting Final Action